Related Experiment Video
Updated: Jun 19, 2026

10:05
The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
Published on: April 28, 2015
Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments
Chi Zhang1, Ziqing Zhao, Nur Aida Abdul Rahim
1Institute of Bioengineering and Nanotechnology, A* STAR, The Nanos, # 04-01, 31 Biopolis Way, Singapore, 138669, Singapore.
Lab on a Chip
|October 30, 2009
Summary
A novel multi-channel 3D microfluidic cell culture system enables simultaneous culture of diverse human cells, mimicking multiple organs for advanced drug screening and reducing animal model reliance.
Area of Science:
- Biotechnology
- Cell Biology
- Drug Discovery
Background:
- Current drug screening methods often rely on animal models, which have limitations in predicting human responses.
- Developing in vitro systems that accurately mimic human physiology is crucial for efficient drug development.
Purpose of the Study:
- To develop and validate a multi-channel 3D microfluidic cell culture system (multi-channel 3D-microFCCS) for simultaneous culture of multiple human cell types.
- To create compartmentalized microenvironments that mimic in vivo conditions for improved drug screening applications.
Main Methods:
- A multi-channel 3D microfluidic system was designed to culture four human cell types (liver, lung, kidney, adipose) in separate compartments.
- Controlled release of growth factors, specifically TGF-beta1, was achieved using gelatin microspheres to create cell-specific microenvironments.
- Cellular functions were monitored to assess the impact of localized growth factor delivery and inter-compartmental cross-talk.
Main Results:
- The multi-channel 3D-microFCCS successfully cultured diverse human cell types, representing multiple organs.
- Specific delivery of TGF-beta1 enhanced lung cell (A549) function without affecting liver (C3A), kidney (HK-2), or adipose (HPA) cell functions.
- Limited cross-talk between compartments was observed, closely resembling in vivo conditions.
Conclusions:
- The developed multi-channel 3D-microFCCS provides a robust platform for in vitro modeling of multiple human organs.
- This system shows significant potential to enhance drug screening accuracy and reduce the need for animal testing in pharmaceutical research.

